Optimizing SDV Frequency for Different Trial Types: Strategies for Efficient Monitoring
Determining how often and how much data to verify depends on multiple factors:
Click to read the full article.
Source Data Verification
Common SDV Errors and Prevention Methods in Clinical Trials
SDV errors refer to mismatches or discrepancies between the data entered into the Case Report Forms (CRFs) and the source documentation maintained by the trial site. These may arise due to incorrect transcription, missing data, untimely updates, or lack of understanding of the protocol requirements.
Click to read the full article.
Training Site Staff for Accurate SDV: Ensuring Data Integrity in Clinical Trials
Site staff should come away from SDV training with the ability to:
Click to read the full article.
Best Practices for SDV in Electronic Medical Record (EMR) Systems
EMRs are digital platforms that store patient information, including clinical visits, medications, diagnoses, test results, and imaging. In clinical trials, EMRs often serve as the primary source of truth for verifying data entered in the Case Report Form (CRF). Since CRAs don’t interact with the patients directly, the EMR is their key validation tool.
Click to read the full article.
Best Practices for SDV in Electronic Medical Record (EMR) Systems
EMRs serve as the official source for clinical information such as diagnoses, lab values, and treatment history. For SDV purposes, CRAs must access specific, protocol-relevant data while ensuring compliance with Good Clinical Practice (GCP) and privacy regulations like USFDA and EMA requirements.
Click to read the full article.
Best Practices for SDV in Electronic Medical Record (EMR) Systems
EMRs serve as the official source for clinical information such as diagnoses, lab values, and treatment history. For SDV purposes, CRAs must access specific, protocol-relevant data while ensuring compliance with Good Clinical Practice (GCP) and privacy regulations like USFDA and EMA requirements.
Click to read the full article.
Protecting Data Privacy and Confidentiality During Source Data Verification (SDV)
Patient confidentiality is a fundamental ethical and legal requirement in clinical trials. During SDV, if privacy safeguards are not followed, there can be risks of data breaches, regulatory non-compliance, and loss of trial credibility. Authorities like the USFDA and EMA mandate that personal health information (PHI) be accessed and handled securely and only by authorized personnel.
Click to read the full article.
How to Document Source Data Verification (SDV) in Monitoring Reports
SDV documentation refers to the section within the MVR where the CRA describes the extent of SDV performed during a site visit, the findings, any discrepancies noted, resolution status, and comments on overall data quality. It serves as a traceable record for sponsors, QA teams, and regulatory auditors.
Click to read the full article.
Creating Effective SDV Plan Templates and SOPs for Clinical Trials
Without standardized procedures, CRAs may perform SDV inconsistently, leading to audit risks, missed data discrepancies, or non-compliance. Regulators such as USFDA and CDSCO expect sponsors to document how data is verified and to have procedures that ensure subject safety and data integrity.
Click to read the full article.
Implementing a Risk-Based Approach to Source Data Verification (SDV)
A risk-based approach to SDV involves prioritizing the verification of data that is critical to subject safety and primary endpoints. Instead of reviewing all data points equally, Clinical Research Associates (CRAs) focus on the areas that have the highest potential to affect trial outcomes or regulatory approval.
Click to read the full article.